What is Scotiabank's Forecast for Nutrien FY2026 Earnings?

Key Points

• Scotiabank raised its FY2026 EPS estimate for Nutrien to $5.12 from $4.82, while maintaining a Sector Outperform rating and an $80 price target.
• Despite the higher forecast, Scotiabank’s FY2026 EPS estimate still sits below the consensus estimate of $5.45 per share. The firm also projected FY2027 EPS of $4.73.
• Nutrien recently posted strong quarterly results, beating earnings and revenue expectations, and it also announced a quarterly dividend of $0.55 per share, equal to a 3.3% annual yield.

Nutrien Ltd. (NYSE:NTR - Free Report) - Investment analysts at Scotiabank raised their FY2026 EPS estimates for shares of Nutrien in a research report issued to clients and investors on Tuesday, July 7th. Scotiabank analyst B. Isaacson now forecasts that the company will earn $5.12 per share for the year, up from their prior forecast of $4.82. Scotiabank currently has a "Sector Outperform" rating and a $80.00 target price on the stock. The consensus estimate for Nutrien's current full-year earnings is $5.45 per share. Scotiabank also issued estimates for Nutrien's FY2027 earnings at $4.73 EPS.

NTR has been the subject of a number of other reports. TD Securities reaffirmed a "buy" rating on shares of Nutrien in a report on Wednesday, May 6th. Raymond James Financial raised Nutrien from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $74.00 to $90.00 in a research note on Tuesday, May 5th. Royal Bank Of Canada upped their price target on Nutrien from $80.00 to $85.00 and gave the stock an "outperform" rating in a report on Tuesday, April 7th. BMO Capital Markets raised their price objective on Nutrien from $85.00 to $90.00 and gave the company an "outperform" rating in a research note on Wednesday, March 18th. Finally, Oppenheimer lifted their price objective on Nutrien from $80.00 to $82.00 and gave the stock an "outperform" rating in a report on Tuesday, May 12th. Thirteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $80.94.

Nutrien Stock Up 2.2%

NTR stock opened at $66.73 on Thursday. The company has a market cap of $31.98 billion, a P/E ratio of 13.59, a P/E/G ratio of 0.60 and a beta of 0.62. Nutrien has a 52 week low of $53.03 and a 52 week high of $85.36. The company's 50-day moving average price is $67.73 and its 200 day moving average price is $69.70. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same quarter last year, the firm posted $0.11 EPS. The business's revenue was up 18.5% compared to the same quarter last year.

Nutrien Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 3.3%. The ex-dividend date is Tuesday, June 30th. Nutrien's dividend payout ratio (DPR) is 44.81%.

Institutional Trading of Nutrien

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Nutrien by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company's stock valued at $1,386,546,000 after purchasing an additional 479,834 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Nutrien by 440.2% during the 4th quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company's stock worth $1,008,713,000 after purchasing an additional 13,313,817 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of Nutrien by 19.1% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company's stock worth $834,962,000 after purchasing an additional 2,276,651 shares during the last quarter. First Eagle Investment Management LLC lifted its stake in Nutrien by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 13,307,283 shares of the company's stock valued at $821,326,000 after buying an additional 70,068 shares in the last quarter. Finally, Deutsche Bank AG lifted its stake in Nutrien by 2.0% in the 4th quarter. Deutsche Bank AG now owns 9,798,196 shares of the company's stock valued at $604,745,000 after buying an additional 189,683 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.